TeenS invention Revolutionizing Emergency Bleeding Control: A Gel That Stops Wounds Fast
MARIETTA, GA – A revolutionary gel designed to rapidly control severe bleeding, invented by a teenager, is gaining traction with first responders and attracting attention from the U.S. Department of Defense. TRAUMAGEL, developed by Cresilon, is poised to become a new standard in emergency trauma care, potentially saving countless lives.
The story began with Joe Landolina, who, as a high school student, witnessed a friend suffer a deep laceration. Frustrated by the limitations of traditional methods to stop the bleeding, Landolina began experimenting in his home lab. This led to the creation of TRAUMAGEL, a plant-derived polysaccharide gel that quickly clots blood upon contact.
“Severe bleeding is the number one cause of preventable death from trauma,” explains Landolina, now CEO and co-founder of Cresilon. “We wanted to create something that was fast, effective, and easy to use, even in the most challenging situations.”
And it is fast. TRAUMAGEL works by rapidly absorbing water from the blood, concentrating clotting factors and forming a stable clot. Cobb County Fire & Emergency Services in Georgia is among the first to adopt the gel, recognizing its potential to dramatically improve patient outcomes.”It’s a game changer,” said a representative from Cobb County Fire & Emergency Services, as shown in a photo accompanying the announcement. “This gel gives us a critical advantage in controlling severe bleeding, buying us valuable time to get patients the definitive care they need.”
The impact isn’t limited to local fire departments. Cresilon is working to get TRAUMAGEL into the hands of first responders nationwide. Beyond civilian applications, the U.S. Defense Department’s Walter Reed Army Institute of Research is currently studying the technology for its potential in treating penetrating traumatic brain injuries (TBI).
“Preliminary findings demonstrated promising results in the ability of our technology to control bleeding and provide neuroprotection following a TBI,” Landolina stated. Further research is planned based on these encouraging initial results.
The potential reach of TRAUMAGEL extends far beyond the battlefield and ambulance. Cresilon envisions a future where the gel is readily available in hospitals, dental offices, and even home first-aid kits, empowering individuals to respond effectively to life-threatening bleeding emergencies.
Want to learn more about protecting your digital life? Take the CyberGuy’s online security quiz: CyberGuy.com/Quiz
Stay informed with Kurt’s CyberGuy Report: CyberGuy.com/Newsletter
Copyright 2025 CyberGuy.com. All rights reserved.
About Kurt Knutsson: Kurt “CyberGuy” Knutsson is an award-winning tech journalist contributing to Fox News & FOX Business, appearing mornings on “FOX & Friends.” He can be reached at CyberGuy.com.
